Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
ClinicalTrials.gov Identifier: NCT04358549
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : June 29, 2020
Study Design
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Open-label, randomized (1:1 ratio) to receive favipiravir plus standard of care or standard of care alone.
Masking: None (Open Label)
Primary Purpose: Treatment
Actual Study Start Date : April 17, 2020
Estimated Primary Completion Date :
August 2020
Estimated Study Completion Date :
December 2020
Locations
HonorHealth(Arizona)
Atlantic Health System / Morristown Medical Center(New Jersey)
Houston Methodist Hospital(Texas)
が追加されている様子
アビガンのアメリカでのテストは6月ぐらいから
対象医療機関が増えているようですね
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
ClinicalTrials.gov Identifier: NCT04358549
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : June 29, 2020
Study Design
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Open-label, randomized (1:1 ratio) to receive favipiravir plus standard of care or standard of care alone.
Masking: None (Open Label)
Primary Purpose: Treatment
Actual Study Start Date : April 17, 2020
Estimated Primary Completion Date :
August 2020
Estimated Study Completion Date :
December 2020
Locations
HonorHealth(Arizona)
Atlantic Health System / Morristown Medical Center(New Jersey)
Houston Methodist Hospital(Texas)
が追加されている様子